Dr Reddy stock at INR 1,197.00, up 1.4 percent today. INE089A01023
Published on 10/09/2026 at 15:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Dr Reddy stock was last at INR 1,197.00 on October 9, 2026, up 1.4 percent from INR 1,180.00.
- Market capitalization stood at INR 997.1 billion, with a P/E ratio of 30.1.
- Trading volume reached 1,510,225 shares against an average volume of 2,044,006.
- Dr. Reddy's Laboratories is scheduled to release second-quarter and half-year results on October 23, 2026.
Dr Reddy stock was last at INR 1,197.00 on the National Stock Exchange on October 9, 2026 at 3:15 p.m. IST, up 1.4 percent from the prior close of INR 1,180.00. The price report centers on valuation, liquidity and the next scheduled results date rather than a company announcement.
Price and trading volume
Trading volume reached 1,510,225 shares on October 9, 2026, below the average volume of 2,044,006 shares. That difference puts the daily move in a measured liquidity setting, with the latest price still inside the 52-week range of INR 1,101.00 to INR 1,414.90 recorded for the same date.
At INR 1,197.00, the stock stood INR 217.90, or 15.4 percent, below its 52-week high. It was INR 96.00, or 8.7 percent, above the 52-week low. These two comparisons place the shares closer to the lower half of the yearly range than to its upper boundary.
Valuation and market size
Dr. Reddy's Laboratories had a market capitalization of INR 997.1 billion on October 9, 2026. Its price-to-earnings ratio was 30.1, giving the valuation a clear numerical anchor for the next results cycle.
The company's official website describes four core businesses: Generics, API and Services, Innovative Medicines and Consumer Health. The portfolio also includes biosimilars, active pharmaceutical ingredients and partnered products, which gives the company several operating categories to update when it reports.
Comparison with peers
Dr Reddy: plus 1.4 percent, P/E 30.1, market capitalization INR 997.1 billion
Sun Pharmaceutical Industries (NSE, INR): plus 0.0 percent, P/E 34.9, market capitalization INR 4,222.8 billion
Cipla (NSE, INR): minus 0.4 percent, P/E 31.2, market capitalization INR 1,051.0 billion
Next results date
According to StockTitan, Dr. Reddy's Laboratories will announce results for the quarter and six months ended September 30, 2026, on October 23, 2026. The scheduled release gives the valuation figures a defined near-term checkpoint.
Dr Reddy stock facts
- Company: Dr. Reddy's Laboratories Limited
- ISIN: INE089A01023
- Ticker: DRREDDY
- Primary exchange: National Stock Exchange of India
- Price on October 9, 2026: INR 1,197.00
- Change versus prior close: plus 1.4 percent
- Prior close: INR 1,180.00
- Market capitalization: INR 997.1 billion (as of October 9, 2026)
- 52-week range: INR 1,101.00-1,414.90 (as of October 9, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
- Next earnings date: October 23, 2026
Market context: Market report BSE Sensex.
